Wilhelm Stoffel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Wilhelm Stoffel has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Erika Binczek
Laboratory of Molecular Neuroscience, Institute of Biochemistry, University of Cologne, 50931, Cologne, Germany
11 shared publicationsBritta Jenke
Laboratory of Molecular Neurosciences, Center of Biochemistry, Faculty of Medicine, University of Cologne, Cologne, Germany; Center of Molecular Medicine, University of Cologne, Cologne, Germany
9 shared publicationsIna Hammels
Laboratory of Molecular Neurosciences, Center of Biochemistry, Faculty of Medicine, University of Cologne, Cologne, Germany; Center of Molecular Medicine, University of Cologne, Cologne, Germany
6 shared publicationsInga Schmidt-Soltau
Center for Molecular Medicine (CMMC), Faculty of Medicine, University of Cologne, 50931, Cologne, Germany
6 shared publicationsMario Thevis
Institute of Biochemistry, Deutsche Sporthochschule Cologne, 50933, Cologne, Germany
5 shared publicationsBarbara Holz
Center of Molecular Medicine (CMMC), Laboratory of Molecular Neurosciences, Institute of Biochemistry, University of Cologne, Cologne, Germany
3 shared publications
Latest Publications
- Open Access
- 14 September 2021
- Published by Elsevier in Molecular Metabolism
- Vol. 54, 101335
High fat / high cholesterol diet does not provoke atherosclerosis in the ω3-and ω6-polyunsaturated fatty acid synthesis–inactivated Δ6-fatty acid desaturase–deficient mouse
- 14 September 2021
- Published by Elsevier in Molecular Metabolism
- Vol. 54, 101335
Open AccessHigh fat / high cholesterol diet does not provoke atherosclerosis in the ω3-and ω6-polyunsaturated fatty acid synthesis–inactivated Δ6-fatty acid desaturase–deficient mouse
- Open Access
- 1 June 2020
- Published by Elsevier in Molecular Metabolism
- Vol. 36, 100974
Dietary ω3-and ω6-Polyunsaturated fatty acids reconstitute fertility of Juvenile and adult Fads2-Deficient mice
- 1 June 2020
- Published by Elsevier in Molecular Metabolism
- Vol. 36, 100974
Open AccessDietary ω3-and ω6-Polyunsaturated fatty acids reconstitute fertility of Juvenile and adult Fads2-Deficient mice
- Open Access
- 1 September 2019
- Published by Elsevier in The American Journal of Pathology
- Vol. 189 (9) , 1831-1845
Neutral Sphingomyelinase 2 (SMPD3) Deficiency in Mice Causes Chondrodysplasia with Unimpaired Skeletal Mineralization
- 1 September 2019
- Published by Elsevier in The American Journal of Pathology
- Vol. 189 (9) , 1831-1845
Open AccessNeutral Sphingomyelinase 2 (SMPD3) Deficiency in Mice Causes Chondrodysplasia with Unimpaired Skeletal Mineralization
- Open Access
- 1 August 2019
- Published by Elsevier in Journal of Lipid Research
- Vol. 60 (8) , 1396-1409
Novel CB1-ligands maintain homeostasis of the endocannabinoid system in ω3- and ω6-long-chain-PUFA deficiency
- 1 August 2019
- Published by Elsevier in Journal of Lipid Research
- Vol. 60 (8) , 1396-1409
Open AccessNovel CB1-ligands maintain homeostasis of the endocannabinoid system in ω3- and ω6-long-chain-PUFA deficiency
- Open Access
- 3 May 2018
- Published by Springer Nature in Cell Death & Disease
- Vol. 9 (5) , 507
SMPD3 deficiency perturbs neuronal proteostasis and causes progressive cognitive impairment
: Neutral sphingomyelinase smpd3 is most abundantly expressed in neurons of brain. The function of SMPD3 has remained elusive. Here, we report a pathogenetic nexus between absence of SMPD3 in the Golgi compartment (GC) of neurons of the smpd3-/- mouse brain, inhibition of Golgi vesicular protein transport and progressive cognitive impairment. Absence of SMPD3 activity in the Golgi sphingomyelin cycle impedes remodeling of the lipid bilayer, essential for budding and multivesicular body formation. Importantly, we show that inhibition of the Golgi vesicular protein transport causes accumulation of neurotoxic proteins APP, Aβ and phosphorylated Tau, dysproteostasis, unfolded protein response, and apoptosis, which ultimately manifests in progressive cognitive decline, similar to the pathognomonic signatures of familial and sporadic forms of Alzheimer´s disease. This discovery might contribute to the search for other primary pathogenic mechanisms, which link perturbed lipid bilayer structures and protein processing and transport in the neuronal Golgi compartment and neurodegeneration and cognitive deficits.
- 3 May 2018
- Published by Springer Nature in Cell Death & Disease
- Vol. 9 (5) , 507
Open AccessSMPD3 deficiency perturbs neuronal proteostasis and causes progressive cognitive impairment
: Neutral sphingomyelinase smpd3 is most abundantly expressed in neurons of brain. The function of SMPD3 has remained elusive. Here, we report a pathogenetic nexus between absence of SMPD3 in the Golgi compartment (GC) of neurons of the smpd3-/- mouse brain, inhibition of Golgi vesicular protein transport and progressive cognitive impairment. Absence of SMPD3 activity in the Golgi sphingomyelin cycle impedes remodeling of the lipid bilayer, essential for budding and multivesicular body formation. Importantly, we show that inhibition of the Golgi vesicular protein transport causes accumulation of neurotoxic proteins APP, Aβ and phosphorylated Tau, dysproteostasis, unfolded protein response, and apoptosis, which ultimately manifests in progressive cognitive decline, similar to the pathognomonic signatures of familial and sporadic forms of Alzheimer´s disease. This discovery might contribute to the search for other primary pathogenic mechanisms, which link perturbed lipid bilayer structures and protein processing and transport in the neuronal Golgi compartment and neurodegeneration and cognitive deficits.
- 1 July 2017
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 137 (7) , 1424-1433
Hair Growth Cycle Is Arrested in SCD1 Deficiency by Impaired Wnt3a-Palmitoleoylation and Retrieved by the Artificial Lipid Barrier
- 1 July 2017
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 137 (7) , 1424-1433
Hair Growth Cycle Is Arrested in SCD1 Deficiency by Impaired Wnt3a-Palmitoleoylation and Retrieved by the Artificial Lipid Barrier
- Open Access
- 24 November 2016
- Published by Springer Nature in Cell Death & Disease
- Vol. 7 (11) , e2488
Neutral sphingomyelinase (SMPD3) deficiency disrupts the Golgi secretory pathway and causes growth inhibition
Systemic loss of neutral sphingomyelinase (SMPD3) in mice leads to a novel form of systemic, juvenile hypoplasia (dwarfism). SMPD3 deficiency in mainly two growth regulating cell types contributes to the phenotype, in chondrocytes of skeletal growth zones to skeletal malformation and chondrodysplasia, and in hypothalamic neurosecretory neurons to systemic hypothalamus–pituitary–somatotropic hypoplasia. The unbiased smpd3−/− mouse mutant and derived smpd3−/− primary chondrocytes were instrumental in defining the enigmatic role underlying the systemic and cell autonomous role of SMPD3 in the Golgi compartment. Here we describe the unprecedented role of SMPD3. SMPD3 deficiency disrupts homeostasis of sphingomyelin (SM), ceramide (Cer) and diacylglycerol (DAG) in the Golgi SMPD3-SMS1 (SM-synthase1) cycle. Cer and DAG, two fusogenic intermediates, modify the membrane lipid bilayer for the initiation of vesicle formation and transport. Dysproteostasis, unfolded protein response, endoplasmic reticulum stress and apoptosis perturb the Golgi secretory pathway in the smpd3−/− mouse. Secretion of extracellular matrix proteins is arrested in chondrocytes and causes skeletal malformation and chondrodysplasia. Similarly, retarded secretion of proteo-hormones in hypothalamic neurosecretory neurons leads to hypothalamus induced combined pituitary hormone deficiency. SMPD3 in the regulation of the protein vesicular secretory pathway may become a diagnostic target in the etiology of unknown forms of juvenile growth and developmental inhibition.
- 24 November 2016
- Published by Springer Nature in Cell Death & Disease
- Vol. 7 (11) , e2488
Open AccessNeutral sphingomyelinase (SMPD3) deficiency disrupts the Golgi secretory pathway and causes growth inhibition
Systemic loss of neutral sphingomyelinase (SMPD3) in mice leads to a novel form of systemic, juvenile hypoplasia (dwarfism). SMPD3 deficiency in mainly two growth regulating cell types contributes to the phenotype, in chondrocytes of skeletal growth zones to skeletal malformation and chondrodysplasia, and in hypothalamic neurosecretory neurons to systemic hypothalamus–pituitary–somatotropic hypoplasia. The unbiased smpd3−/− mouse mutant and derived smpd3−/− primary chondrocytes were instrumental in defining the enigmatic role underlying the systemic and cell autonomous role of SMPD3 in the Golgi compartment. Here we describe the unprecedented role of SMPD3. SMPD3 deficiency disrupts homeostasis of sphingomyelin (SM), ceramide (Cer) and diacylglycerol (DAG) in the Golgi SMPD3-SMS1 (SM-synthase1) cycle. Cer and DAG, two fusogenic intermediates, modify the membrane lipid bilayer for the initiation of vesicle formation and transport. Dysproteostasis, unfolded protein response, endoplasmic reticulum stress and apoptosis perturb the Golgi secretory pathway in the smpd3−/− mouse. Secretion of extracellular matrix proteins is arrested in chondrocytes and causes skeletal malformation and chondrodysplasia. Similarly, retarded secretion of proteo-hormones in hypothalamic neurosecretory neurons leads to hypothalamus induced combined pituitary hormone deficiency. SMPD3 in the regulation of the protein vesicular secretory pathway may become a diagnostic target in the etiology of unknown forms of juvenile growth and developmental inhibition.
- 30 December 2013
- Published by Springer Nature in EMBO Reports
- Vol. 15 (1) , 110-120
Obesity resistance and deregulation of lipogenesis in Δ6‐fatty acid desaturase (FADS2) deficiency
Δ‐6‐fatty acid desaturase (FADS2) is the key enzyme in the biosynthesis of polyunsaturated fatty acids (PUFAs), the essential structural determinants of mammalian membrane lipid‐bilayers. We developed the auxotrophic fads2 −/− mouse mutant to assess the enigmatic role of ω3‐ and ω6‐PUFAs in lipid homeostasis, membrane structure and function. Obesity resistance is another major phenotype of the fads2 −/− mutant, the molecular basis of which is unknown. Phospholipidomic profiling of membrane systems of fads2 −/− mice revealed diacylglycerol‐structures, deprived of PUFAs but substituted with surrogate eicosa‐5,11,14‐trienoic acid. ω6‐Arachidonic (AA) and ω3‐docosahexaenoic acid (DHA) supplemented diets transformed fads2 −/− into AA‐fads2 −/− and DHA‐fads2 −/− mutants. Severely altered phospholipid‐bilayer structures of subcellular membranes of fads2 −/− liver specifically interfered with maturation of transcription factor sterol‐regulatory‐element‐binding protein, the key regulator of lipogenesis and lipid homeostasis. This study strengthens the concept that specific PUFA‐substituted membrane phospholipid species are critical constituents of the structural platform operative in lipid homeostasis in normal and disease conditions. ![][1] Systemic absence of ω3‐ and ω6‐polyunsaturated fatty acid (PUFA) in Δ6‐fatty acid desaturase deficiency (fads2‐/‐) causes pleiotropy, of which obesity resistance and deregulation of lipogenesis are described here. [1]: pending:yes
- 30 December 2013
- Published by Springer Nature in EMBO Reports
- Vol. 15 (1) , 110-120
Obesity resistance and deregulation of lipogenesis in Δ6‐fatty acid desaturase (FADS2) deficiency
Δ‐6‐fatty acid desaturase (FADS2) is the key enzyme in the biosynthesis of polyunsaturated fatty acids (PUFAs), the essential structural determinants of mammalian membrane lipid‐bilayers. We developed the auxotrophic fads2 −/− mouse mutant to assess the enigmatic role of ω3‐ and ω6‐PUFAs in lipid homeostasis, membrane structure and function. Obesity resistance is another major phenotype of the fads2 −/− mutant, the molecular basis of which is unknown. Phospholipidomic profiling of membrane systems of fads2 −/− mice revealed diacylglycerol‐structures, deprived of PUFAs but substituted with surrogate eicosa‐5,11,14‐trienoic acid. ω6‐Arachidonic (AA) and ω3‐docosahexaenoic acid (DHA) supplemented diets transformed fads2 −/− into AA‐fads2 −/− and DHA‐fads2 −/− mutants. Severely altered phospholipid‐bilayer structures of subcellular membranes of fads2 −/− liver specifically interfered with maturation of transcription factor sterol‐regulatory‐element‐binding protein, the key regulator of lipogenesis and lipid homeostasis. This study strengthens the concept that specific PUFA‐substituted membrane phospholipid species are critical constituents of the structural platform operative in lipid homeostasis in normal and disease conditions. ![][1] Systemic absence of ω3‐ and ω6‐polyunsaturated fatty acid (PUFA) in Δ6‐fatty acid desaturase deficiency (fads2‐/‐) causes pleiotropy, of which obesity resistance and deregulation of lipogenesis are described here. [1]: pending:yes
- 14 February 2012
- Published by Springer Nature in Journal of the Association for Research in Otolaryngology
- Vol. 13 (3) , 323-333
Altered Phenotype of the Vestibular Organ in GLAST-1 Null Mice
Various studies point to a crucial role of the high-affinity sodium-coupled glutamate aspartate transporter GLAST-1 for modulation of excitatory transmission as shown in the retina and the CNS. While 2–4-month-old GLAST-1 null mice did not show any functional vestibular abnormality, we observed profound circling behavior in older (7 months) animals lacking GLAST-1. An unchanged total number of otoferlin-positive vestibular hair cells (VHCs), similar ribbon numbers in VHCs, and an unchanged VGLUT3 expression in type II VHCs were detected in GLAST-1 null compared to wild-type mice. A partial loss of supporting cells and an apparent decline of a voltage-gated channel potassium subunit (KCNQ4) was observed in postsynaptic calyceal afferents contacting type I VHCs, together with a reduction of neurofilament- (NF200-) and vesicular glutamate transporter 1- (VGLUT1-) positive calyces in GLAST-1 null mice. Taken together, GLAST-1 deletion appeared to preferentially affect the maintenance of a normal postsynaptic/neuronal phenotype, evident only with increasing age.
- 14 February 2012
- Published by Springer Nature in Journal of the Association for Research in Otolaryngology
- Vol. 13 (3) , 323-333
Altered Phenotype of the Vestibular Organ in GLAST-1 Null Mice
Various studies point to a crucial role of the high-affinity sodium-coupled glutamate aspartate transporter GLAST-1 for modulation of excitatory transmission as shown in the retina and the CNS. While 2–4-month-old GLAST-1 null mice did not show any functional vestibular abnormality, we observed profound circling behavior in older (7 months) animals lacking GLAST-1. An unchanged total number of otoferlin-positive vestibular hair cells (VHCs), similar ribbon numbers in VHCs, and an unchanged VGLUT3 expression in type II VHCs were detected in GLAST-1 null compared to wild-type mice. A partial loss of supporting cells and an apparent decline of a voltage-gated channel potassium subunit (KCNQ4) was observed in postsynaptic calyceal afferents contacting type I VHCs, together with a reduction of neurofilament- (NF200-) and vesicular glutamate transporter 1- (VGLUT1-) positive calyces in GLAST-1 null mice. Taken together, GLAST-1 deletion appeared to preferentially affect the maintenance of a normal postsynaptic/neuronal phenotype, evident only with increasing age.
- Open Access
- 7 August 2008
- Published by Springer Nature in The EMBO Journal
- Vol. 27 (17) , 2281-2292
Δ6‐Desaturase (FADS2) deficiency unveils the role of ω3‐ and ω6‐polyunsaturated fatty acids
Mammalian cell viability is dependent on the supply of the essential fatty acids (EFAs) linoleic and α‐linolenic acid. EFAs are converted into ω3‐ and ω6‐polyunsaturated fatty acids (PUFAs), which are essential constituents of membrane phospholipids and precursors of eicosanoids, anandamide and docosanoids. Whether EFAs, PUFAs and eicosanoids are essential for cell viability has remained elusive. Here, we show that deletion of Δ6‐fatty acid desaturase (FADS2) gene expression in the mouse abolishes the initial step in the enzymatic cascade of PUFA synthesis. The lack of PUFAs and eicosanoids does not impair the normal viability and lifespan of male and female fads2−/− mice, but causes sterility. We further provide the molecular evidence for a pivotal role of PUFA‐substituted membrane phospholipids in Sertoli cell polarity and blood–testis barrier, and the gap junction network between granulosa cells of ovarian follicles. The fads2−/− mouse is an auxotrophic mutant. It is anticipated that FADS2 will become a major focus in membrane, haemostasis, inflammation and atherosclerosis research.
- 7 August 2008
- Published by Springer Nature in The EMBO Journal
- Vol. 27 (17) , 2281-2292
Open AccessΔ6‐Desaturase (FADS2) deficiency unveils the role of ω3‐ and ω6‐polyunsaturated fatty acids
Mammalian cell viability is dependent on the supply of the essential fatty acids (EFAs) linoleic and α‐linolenic acid. EFAs are converted into ω3‐ and ω6‐polyunsaturated fatty acids (PUFAs), which are essential constituents of membrane phospholipids and precursors of eicosanoids, anandamide and docosanoids. Whether EFAs, PUFAs and eicosanoids are essential for cell viability has remained elusive. Here, we show that deletion of Δ6‐fatty acid desaturase (FADS2) gene expression in the mouse abolishes the initial step in the enzymatic cascade of PUFA synthesis. The lack of PUFAs and eicosanoids does not impair the normal viability and lifespan of male and female fads2−/− mice, but causes sterility. We further provide the molecular evidence for a pivotal role of PUFA‐substituted membrane phospholipids in Sertoli cell polarity and blood–testis barrier, and the gap junction network between granulosa cells of ovarian follicles. The fads2−/− mouse is an auxotrophic mutant. It is anticipated that FADS2 will become a major focus in membrane, haemostasis, inflammation and atherosclerosis research.